Bilcare GCS Opens New Global U.S. Headquarters
Bilcare Global Clinical Supplies, a single-source provider of clinical trial services, announced that ithas opened its new global U.S. headquarters in San Francisco.
Bilcare GCS Opens New Global U.S. Headquarters
San Francisco, CA – July 31, 2008 - Bilcare Global Clinical Supplies, a
leading single-source provider of clinical trial services, announced that it
has opened its new global U.S. headquarters in San Francisco. The
headquarters, which will be led by CEO Vito Mangiardi, operates as the
company’s corporate hub to drive growth in Bilcare’s American, European, and
Asian regions.
“This year has been one of substantial growth in every area of our global
business, from staffing and facilities to equipment and services,” said
Mangiardi. “While our U.S., India, and Wales-based facilities manage the
increased demand for research and packaging services, our headquarters will
dedicate itself to furthering global integration and growing the company as
a full-service solutions provider that can take customers from research and
development, to Phase I and II trials, and through longer-term Phase III
trials.”
The opening of Bilcare GCS’ global headquarters marks the latest development
in the company’s significant growth. During its 2007-2008 fiscal year,
Bilcare GCS nearly doubled its global workforce, including significant
additions to its executive team; completed a US$2.3 million capital
investment program in the U.S.; expanded its facility in Rajgurunagar, near
Pune, India; plans US$21 million towards a new clinical supplies facility in
South Wales; and made significant global investments in technology, project
management, and quality standards to help drive customer satisfaction and
success. Other investments include new integrated business processes that
span the entire clinical supply chain and cutting-edge technology solutions
including interactive voice response/interactive web response (IVR/IWR)
services.
“Bilcare has built its reputation on providing customers with the
highest-quality clinical supplies and research services, delivered on time,
every time,” said Mangiardi. “Our new headquarters will allow us to take
our services to the next level while continuing to provide the quality and
attention that customers expect and deserve.”
About Bilcare Global Clinical Supplies
Bilcare Global Clinical Supplies serves the Americas, Europe, and Asia with
clinical trial materials support, services, and complete project management.
Its services for solid, semi-solid, liquid, DEA (CI-V) and biotech clinical
trial materials (CTM) satisfy a broad range of requirements; from
pre-formulation research and development, manufacturing, analytical services
and clinical supplies packaging and labeling, to IVRS, QP services,
controlled temperature (cold and frozen chain) CTM storage, distribution
worldwide, and returns and destructions accountability.
For more information about Bilcare Global Clinical Supplies, visit
www.BilcareGCS.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
